Obserwuj
Thomas Verstraeten
Thomas Verstraeten
P95
Zweryfikowany adres z p-95.com - Strona główna
Tytuł
Cytowane przez
Cytowane przez
Rok
Burden of rotavirus disease in European Union countries
M Soriano-Gabarró, J Mrukowicz, T Vesikari, T Verstraeten
The Pediatric infectious disease journal 25 (1), S7-S11, 2006
5222006
Safety of thimerosal-containing vaccines: a two-phased study of computerized health maintenance organization databases
T Verstraeten, RL Davis, F DeStefano, TA Lieu, PH Rhodes, SB Black, ...
Pediatrics 112 (5), 1039-1048, 2003
3662003
Vaccinations and risk of central nervous system demyelinating diseases in adults
F DeStefano, T Verstraeten, LA Jackson, CA Okoro, P Benson, SB Black, ...
Archives of Neurology 60 (4), 504-509, 2003
2972003
Safety of human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine for cervical cancer prevention: a pooled analysis of 11 clinical trials
D Descamps, K Hardt, B Spiessens, P Izurieta, T Verstraeten, T Breuer, ...
Human vaccines 5 (5), 332-340, 2009
2282009
Analysis of adverse events of potential autoimmune aetiology in a large integrated safety database of AS04 adjuvanted vaccines
T Verstraeten, D Descamps, MP David, T Zahaf, K Hardt, P Izurieta, ...
Vaccine 26 (51), 6630-6638, 2008
1792008
Prospective multinational study of pertussis infection in hospitalized infants and their household contacts
F Kowalzik, AP Barbosa, VR Fernandes, PR Carvalho, ML Avila-Aguero, ...
The Pediatric infectious disease journal 26 (3), 238-242, 2007
1782007
The use of combination vaccines has improved timeliness of vaccination in children
H Kalies, V Grote, T Verstraeten, L Hessel, HJ Schmitt, R von Kries
The Pediatric infectious disease journal 25 (6), 507-512, 2006
1632006
A retrospective cohort study of the association of varicella vaccine failure with asthma, steroid use, age at vaccination, and measles-mumps-rubella vaccination
T Verstraeten, AO Jumaan, JP Mullooly, JF Seward, HS Izurieta, ...
Pediatrics 112 (2), e98-e103, 2003
1332003
Postmarketing surveillance of intussusception following mass introduction of the attenuated human rotavirus vaccine in Mexico
FR Velázquez, RE Colindres, C Grajales, MT Hernández, MG Mercadillo, ...
The Pediatric infectious disease journal 31 (7), 736-744, 2012
1252012
Regression models for disease prevalence with diagnostic tests on pools of serum samples
S Vansteelandt, E Goetghebeur, T Verstraeten
Biometrics 56 (4), 1126-1133, 2000
1092000
Impact of universal varicella vaccination on 1-year-olds in Uruguay: 1997–2005
J Quian, R Rüttimann, C Romero, P Dall’Orso, A Cerisola, T Breuer, ...
Archives of disease in childhood 93 (10), 845-850, 2008
1082008
Safety of MF59-adjuvanted A/H1N1 influenza vaccine in pregnancy: a comparative cohort study
T Heikkinen, J Young, E van Beek, H Franke, T Verstraeten, JG Weil, ...
American journal of obstetrics and gynecology 207 (3), 177. e1-177. e8, 2012
1062012
Rotavirus serotype G9 is associated with more-severe disease in Latin America
AC Linhares, T Verstraeten, J Wolleswinkel-van den Bosch, R Clemens, ...
Clinical infectious diseases 43 (3), 312-314, 2006
982006
Pregnancy and safety outcomes in women vaccinated with an AS03-adjuvanted split virion H1N1 (2009) pandemic influenza vaccine during pregnancy: a prospective cohort study
F Tavares, I Nazareth, JS Monegal, I Kolte, T Verstraeten, V Bauchau
Vaccine 29 (37), 6358-6365, 2011
792011
Enhancing vaccine safety surveillance: a capture-recapture analysis of intussusception after rotavirus vaccination
T Verstraeten, AL Baughman, B Cadwell, L Zanardi, P Haber, RT Chen, ...
American journal of epidemiology 154 (11), 1006-1012, 2001
782001
Phase 1 assessment of the safety and immunogenicity of an mRNA-lipid nanoparticle vaccine candidate against SARS-CoV-2 in human volunteers
P Kremsner, P Mann, J Bosch, R Fendel, JJ Gabor, A Kreidenweiss, ...
MedRxiv, 2020
762020
Review of 8 years of experience with Infanrix hexa™(DTPa–HBV–IPV/Hib hexavalent vaccine)
F Zepp, HJ Schmitt, J Cleerbout, T Verstraeten, L Schuerman, JM Jacquet
Expert review of vaccines 8 (6), 663-678, 2009
762009
A decade of norovirus disease risk among older adults in upper-middle and high income countries: a systematic review
L Lindsay, J Wolter, I De Coster, P Van Damme, T Verstraeten
BMC Infectious diseases 15 (1), 1-16, 2015
742015
Unusual cutaneous lesions in two patients with visceral leishmaniasis and HIV infection
R Colebunders, K Depraetere, T Verstraeten, J Lambert, E Hauben, ...
Journal of the American Academy of Dermatology 41 (5), 847-850, 1999
731999
A systematic review of varicella seroprevalence in European countries before universal childhood immunization: deriving incidence from seroprevalence data
K Bollaerts, M Riera-Montes, U Heininger, N Hens, A Souverain, ...
Epidemiology & Infection 145 (13), 2666-2677, 2017
712017
Nie można teraz wykonać tej operacji. Spróbuj ponownie później.
Prace 1–20